Share of Natco Pharma rose 20 per cent to hit a fresh 52-week high of Rs 1188.95 in early tradeafter the Drug Controller General of India (DCGI) gave its nod to the firm start manufacturing antifungal anti-fungal drug Amphotericin B liposomal injection. Its demand has increased in the wake of a surge in black fungus infections. Four other firms Alembic Pharmaceuticals, Emcure Pharmaceuticals, Gufic Biosciences and Lyca Pharmaceuticals have also received DCGI's permission to produce the injection.

Leave a Reply

Your email address will not be published. Required fields are marked *